The biocompatibility, stability and reproducibility of this novel method allows its industrial production for uses such as personalized therapy. The Nanomedicine Group of the Marqués de Valdecilla Health Research Institute (IDIVAL) has designed and optimized a novel method based on nanoparticles capable of encapsulating, storing and transferring genetic material into cells. The procedure is easily […]
Researchers from the IDIVAL neurodegenerative diseases group and the Movement Disorders Unit of the Marqués de Valdecilla University Hospital (HUMV) have participated in a recent study, promoted by the Clínic Barcelona-IDIBAPS, which has detected alterations in the expression profile of four microRNAs, which could make it possible to detect the onset of genetic Parkinson’s disease […]
Care4Diabetes aims to empower patients to take an active role in the management of their disease. Endocrinologist Luis Alberto Vazquez Salví took part in the project’s inaugural conference held on 16 and 17 February in Oviedo with all the partners involved in Care4Diabetes. The aim is to implement in the European Union the Reverse Diabetes2 […]
Primary care is a key priority in terms of elements needed to strengthen the resilience of health systems, as well as to improve their accessibility. The new EU4Health funded Joint Action CIRCE-JA aims to improve and foster health in the European Union and strengthen health systems through reinforcing primary health care. CIRCE-JA is a 36-month […]
IDIVAL has collaborated on the new Cantabrian Health Service application MiSalud@SCS, launched on 5 December, which to date has had more than 22,000 users in its first month of operation. The collaboration of the Valdecilla Research Institute (IDIVAL) together with the Cantabrian School of Health was key in the app usability tests carried out, based […]
Lorem ipsum dolor sit amet consectetur adipisicing elit. Molestiae, perspiciatis tempora consequatur ratione commodi distinctio, reprehenderit, nostrum non inventore error facere. Deleniti delectus, aliquid quam neque perspiciatis officiis repellat cum.Iusto odit dolorem obcaecati consectetur voluptates at, distinctio alias tenetur neque cupiditate laboriosam facilis expedita soluta provident quas dolorum adipisci quidem modi harum perferendis corporis sapiente […]
From a motor point of view, Parkinson's disease has traditionally been classified into different clinical phenotypes, which may be associated with a different prognosis of the disease. Tremor-predominant subtypes have been associated with more favourable prognoses than non-tremor subtypes. IDIVAL's neurodegenerative diseases group has been participating in the COPPADIS study since 2016. This […]
The IDIVAL Strategic Plan is the planning document that sets out the Institute's strategic objectives and action plans. During the year 2021, work has been done on the preparation of the new Strategic Plan, which is valid for the period 2022-2026. A significant number of members and staff of the Institute participated and collaborated in […]
An online study visit was hosted by the Health Research Institute Marqués de Valdecila (IDIVAL). The sessionwas attended by the INTENCIVE partner countries, some members of the regional stakeholder working groups as well as other people interested in the topics covered. In total, there were more than 40 attendees. This meeting was focused on our […]
The LXXXIII Meeting of the Lymphoma Club of the Spanish Society of Pathological Anatomy (SEAP) will be held on the 24th of September at the Palacio de la Magdalena. The meeting is organised by Dr. Enrique Ocio, head of the Haematology Service and Dr. Santiago Montes from the Pathology Department of the Marqués de Valdecilla […]
